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Two types of melanogenesis, eumelanogenesis and pheome­
lanogenesis, can be switched from one type to another under 
certain physiologic or pathologic conditions. To study the 
regulation of melanogenesis, we developed a high-perform­
ance liquid chromatography method to analyze quantita­
tively the contents of eu- and pheomelanin in tissue samples 
without any isolation procedures. The rationale is that per­
manganate oxidation of eumelanin yields pyrrole-2,3,S-tri­
carboxylic acid, which may serve as a quantitatively signifi­
cant indicator of eumelanin, whereas hydriodic acid 
hydrolysis of pheomelanin yields aminohydroxyphenylala­
nine as a specific indicator of pheomelanin. The method has 
been successfully applied to the analysis of eu- and pheome­
lanin not only in synthetic melanins, melanosomes, hair, 
feathers, and melanomas, but also in human epidermis and 
T
wo types of melanogenesis occur in mammals: eume­
lanogenesis and pheomelanogenesis as seen in 
C57BL/10J black and lethal yellow mice, respec­
tively [1]. A switch in the synthesis of one type to that 
of the other is stimulated by certain chemicals, such as 
a-melanocyte-stimulating hormone (MSH). This switching can 
also proceed naturally as seen in the agouti mouse, which is charac­
terized by black hair with a subterminal yellow band [1]. This 
switching takes place within the same melanocyte. 
In melanocytes, a specific enzyme tyrosinase catalyzes two succes­
sive reactions, hydroxylation of tyrosine and oxidation of dopa. 
Thus, tyrosinase oxidizes tyrosine to dopa and then to dopaquinone, 
which is cyclized to leucodopachrome in a rapid, non-enzymic reac­
tion. A rapid oxidation of leucodopachrome, catalyzed by dopa­
quinone, gives a red pigment dopachrome, which in tum is con­
verted to 5,6-dihydroxyindole by decarboxylation or its carboxy 
derivative by tautomerization (Fig 1) [2,3]. The latter reaction is 
shown to be catalyzed by an enzyme dopachrome tautomerase, orig-
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cultured melanocytes. These studies indicate that there exists 
an inverse relationship between the contents of eu- and 
pheomelanin. We propose that the switching between the 
two types of melanogenesis is mainly controlled by the level 
of tyrosinase activity: higher activity leads to eumelanogene­
sis and lower activity leads to pheomelanogenesis. When 
tyrosinase activity is low, dopaquinone, a reactive interme­
diate in melanogenesis, is quantitatively converted to glu­
tathionyldopa, which gives rise exclusively to pheomelanin. 
When tyrosinase activity is high, an excess of dopaquinone is 
produced, which results in the inactivation of glutathione 
reductase and y-glutamyl transpeptidase, enzymes essential 
for pheomelanogenesis. These biochemical events eventu­
ally leads to eumelanogenesis. ] Invest Dermatol 100: 166S-
171S,1993 
inally called dopachrome conversion factor [4]. These dihydroxyin­
doles are highly reactive and are further oxidized to give rise to 
eumelanin polymer. If dopaquinone encounters cysteine or glutathi­
one (GSH), cysteinyldopas (cys-dopas) are formed either directly or 
indirectly through glutathionyldopas (glu-dopas). The glu-dopa 
pathway requires intervention of y-glutamyl transpeptidase (y­
GTP) and a peptidase [5]. Pheomelanin is then formed via benzoth­
iazine derivatives by oxidation of cys-dopas, catalyzed by dopaquin­
one. Co-polymerization of dopa and cys-dopas leads to the 
production of mixed-type melanin [2,3]. 
We describe here the development and application of our high­
performance liquid chromatography (HPLC) method to analyze 
quantitatively the contents of eu- and pheomelanin in tissue samples 
and propose a hypothesis that the switching of eu- and pheomelanin 
production is mainly controlled by the level of tyrosinase activity. 
Comparison of Eumelanin and Pheomelanin Properties of 
eumelanin and pheomelanin are compared in Table I. The color of 
tissues containing eumelanin is generally thought to be dark brown 
to black, whereas those containing pheomelanin are yellow to red­
dish brown. However, one cannot differentiate between dark 
brown and reddish brown with certainty. In fact, our HPLC analy­
ses have proved that the visual criteria are not reliable [6-10]. Dif­
ferences in solubility are by no means reliable, as eumelanin is also 
slightly soluble in strong alkali, the property serving a basis for the 
spectroscopic assay of melanin (eumelanin) [11]. When isolated 
without any structural modification, differences in the elemental 
content of sulfur serve to distinguish pheomelanin from eumelanin. 
High sulfur content in some melanins isolated from hair, feathers, 
and melanomas has been attributed to co-polymerization of the two 
types of melanins [2]. However, we have recently shown that as 
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Figure 1. Outlines of eumelanogenesis and pheomelanogenesis in me1a­
nocytes. 
much as 1-2% of sulfur is incorporated into melanin during isola­
tion procedures [12]. Ellipsoidal-lamellar melanosomes are found 
associated with eumelanogenesis, whereas spherical-granular ones 
are found associated with pheomelanogenesis [1,6]. However, this 
differentiation does not necessarily hold in melanomas [13]. Dopa 
and cys-dopas cannot be used as specific indicators of eu- and pheo­
melanogenesis. A high level of 5-S-cys-dopa was detected in B16 
mouse melanomas that produce almost pure eumelanin [14]. As 
5,6-dihydroxyindoles are intermediates specific for eumelanogene­
sis, their levels may be considered to reflect the degree of eumelano­
genesis [15]. Thus, at present, the only property that can be used to 
Table I. Comparison of Properties of Eumelanin 
and Pheomelanin 
Property Eumelanin Pheomelanin Specificity 
Color Dark brown to black Yellow to red- Low 
(of tissue) dish brown 
Solubility Insoluble in acid and Soluble in alkali Low 
alkali 
IDemental C, H,O, C, H,O, Low 
composi- N (6-9%), N (8-11%), 
tion S (9-12%) 
S(O-I%) 
Melanosome Ellipsoidal-lamellar Spherical- Low 
ultrastruc- granular ture 
Ultimate Dopa Cysteinyldopas Low 
precursor 5,6-Dihydroxyindole High 
(-2 -carboxylic acid) 
Monomer 5,6-Dihydroxyindole Benzothiazine High 
units ( -2 -carboxylic acid) derivatives 
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Figure 2. Chemical degradation of eumelanin and pheomelanin. 
disti�guish sp�cifically between e?- and pheomelanin appears to be 
the difference In the monomer umts of these two types of melanins. 
HPLC Analysis of Eumelanin and Pbeomelanin The 
previ�us methods �or the quantitation of melanin in tissues required 
lsolatlOn of melanm and were not suitable for distinguishing be­
tween eu- and pheomelanin [11]. To study the regulation of melano­
genesis, it is essential to analyze not only the amount but also the 
type of melanin produced. We therefore developed a HPLC 
method to analyze quantitatively the contents of eu- and yheome­
lanin in �ssue samples without any isolation procedures P6]. The 
m�thod 15 based on the formation of pyrrole-2,3,5-tricarboxylic 
aCld (PTC�) by permanganate oxidation and of amino hydroxy­
phenylalamne (AHP) isomers by hydriodic acid hydrolysis (Fig 2). 
These specific products are determined by HPLC. The original 
I?ethod was later improved to increase the sensitivity and reduce the 
tlme for pre-HPLC workup [17]. The improved method requires 
only 5 mg or less of tissue samples or 106 cultured cells for each 
analysis. The yields of PTCA and AHP are 20/0 and 20% from eu­
and pheomelanin, respectively. The tissue contents of eu- and 
pheomelanin can therefore be estimated by multiplying the PTCA 
and AHP contents by factors of 50 and 5, respectively [17]. Thus, 
the PTCA/ AHP ratio of 0.1 indicates a mixture consisting of equal 
amounts of eu- and pheomelanin. 
Our HPLC method �as been successfully applied to the analysis 
?f eu- and pheomelanm not only in synthetic melanins [12,18], 
ls�lated melanosomes [13,16,17], hair [6-10,19-21], feathers [22], 
skin [23], and melanomas [16,17], but also in human epidermis [24] 
and .culture.d melanocytes [25]. Most of these analyses have been carned out In our laboratory as collaborative studies. However, sev­
eral other laboratories have also started to apply our method to their 
studies [2� -31]. It should be �dded that the same methodology has 
been apphed to analyze melamns produced from cysteinyldopamine 
[32] and cysteinyl-3,4-di�ydroxyphenylacetic acid [33]. The only 
other method to charactenze eu- and pheomelanin is the application 
of electron spin resonance spectroscopy [34]. The method has re­
cently been applied to analyze eu- and pheomelanin in lamb hair and 
the results show that th� electron spin resonance spectroscopic 
method correlates well WIth the HPLC method although it lacks 
the sensitivity of the latter with respect to pheomelanin analysis 
[21]. 
Application of HPLC Analysis of Eu- and Pbeomelanin 
We have carried out a collaborative study on the regulation of eu­
and pheomelanogenesis in follicular melanocytes of viable yellow 
(C3H_He�*VY) mice [20]. These mice grow yellow hair after birth, 
brown hatr at puberty, and yellow hair again at 5 months of age. 
Pluc�ng of the hair induced an increase in skin tyrosinase, the levels 
of whlch were about two times higher in the pubertal mice than in 
the adult mice. The brown hair that grew in the plucked area of the 
pubertal mice contained over 20 times more eumelanin (PTCA) 
than the yellow hair of the adult mice, whereas the pheomelanin 
(AHP) content was half that in the brown hair. Administration of 
a-MSH to plucked pubertal mice increased skin tyrosinase level 
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Figure 3. Contents of eumelanin and pheomelanin in hair grown in the 
area of plucking from viable yellow mice. Effects of a-MSH and bromo­
criptine are compared. Adapted from Table I of [20]. Note that the eu- and 
pheomelanin contents can be estimated by multiplying the PTCA and 
AHP contents by factors of 50 and 5, respectively. 
about twofold over the control. This treatment increased the dark­
ness of the hair that grew in the plucked area from brown to dark 
brown. There was a considerable increase in the eumelanin content 
with a slight decrease in the pheomelanin content (Fig 3). 
On the other hand, when bromocriptine, a dopamine agonist, 
was administered to pubertal mice, the tyrosinase activity in the 
plucked area showed almost no increase and was less than 10% of 
the a-MSH treated mice. This treatment decreased darkness of the 
hair from brown to yellow. This color change was reflected by the 
melanin content of hair. Thus after bromocriptine treatment the 
eumelanin content showed a tenfold reduction, whereas the pheo­
melanin content showed a twofold increase. 
In another collaborative study we analyzed eumelanin and pheo­
melanin contents in hair from variously colored sheep [9]. It was 
found that only the black and white groups are distinct and non­
black groups consisting of brown, red, and tan overlap with each 
other, showing a broad spectrum of eu- and pheomelanin contents 
(Fig 4). It can be seen that the reduction in eumelanin content is 
accompanied by a concomitant increase in pheomelanin content and 
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Figure 4. Contents of eumelanin and pheomelanin in hair from sheep of 
various colors. Adapted from Fig 2 of [9]. 
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Figure S. Contents of eumelanin and pheomelanin in hair from sheep of 
various colors. Adapted from Table II of (10] and Table I of [24]. 
at a certain point contents of both eu- and pheomelanin start to 
decrease in a parallel fashion. The switch toward mixtures with 
more pheomelanin is associated with an overall reduction in mela­
nin content. 
A similar type of phenomenon was also observed in human hair. 
As shown in Fig 5, the reduction in eumelanin content is accompa­
nied by the increase in pheomelanin content [10]. 
I 
Hypothesis for the Mechanism of Switching Between Eu- ' 
and Pheomelanogenesis In follicular melanocytes, melanogen­
esis is strictly regulated by genetic factors [1]. Non-agouti (aja) 
mice produce pure eumelanin, whereas lethal yellow (AI ja) mice 
synthesize only pheomelanin, as assayed by our HPLC method [17]. 
We have shown in this review that pheomelanogenesis can proceed 
when levels of tyrosinase activity are much lower than are required 
for eumelanogenesis. Also, there is an inverse relationship between 
the contents of eu- and pheomelanin. Finally, the switch to pheo­
melanogenesis is accompanied by a reduction in total melanin con­
tent. 
An analysis of the metabolic pathway leading to eu- and pheome­
lanogenesis indicates that one obvious control point is the availabil­
ity of sulfhydryl compounds in the melanosome (Fig 1). As the 
addition reaction of cysteine, GSH, or related sulfhydryl com­
pounds is an extremely fast process [35], cys-dopas or glu-dopas are 
quantitatively produced as long as cysteine or GSH is present. Theo­
retically, eumelanogenesis can therefore proceed only when these 
sulfhydryl compounds are not available for the reaction with dopa­
:quinone. However, it is very unlikely that melanosomes are com­
pletely devoid of cysteine or GSH. There are two theories as to how 
cys-dopas are formed in the melanosome. One is the direct forma­
tion by the addition of cysteine to dopaquinone [36,37] and the 
other is the indirect formation through the enzymic hydrolysis of 
glu-dopas produced by the addition of GSH to dopaquinone [2,3] . 
As GSH is the major intracellular non-protein sulfhydryl com­
pound and the level of cysteine is less than 5% of GSH [38], we favor 
here the latter, glu-dopa pathway. 
Prota proposed that melanogenesis switching is mainly con­
trolled by the levels of GSH and glutathione reductase (GR) [2,3]. In 
support of this view, Benedetto et al [38,39] found lower levels of 
GSH and GR activity in eumelanin-producing skin and higher 
levels in pheomelanin-producing skin from rodents of different 
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Figure 6. Hypothesis for the mechanism of switching between eu- and 
pheomelanogenesis: regulation by tyrosinase activity. 
colors. ),-GTP is also suggested to be involved in pheomelanogene­
sis [40,41]. We can therefore hypothesize that pheomelanogenesis 
can proceed when the levels of GSH and ),-GTP activity are high 
enough to trap any dopaquinone formed and hydrolyze glu-dopas 
thus formed. However, how eumelanogenesis can proceed is an­
other, although related, problem to be solved. We have previously 
shown that eumelanins isolated from C57 black hair, B16 mela­
noma, and sepia ink are almost free from incorporati0':l of not only 
cysteine but also GSH [12]. Therefore, any hypotheslS to account 
for the switching mechanism should explain how sulfhydryl com­
pounds are excluded from being incorporated into melanin in eu­
melanin-producing melanosomes. 
We now propose that the switching between eu- .and phe?�e­lanogenesis is mainly controlled by the level of tyrosmase actIVlty: 
higher tyrosinase activity leads. to e';1melanogenesis and lowe� activ­ity leads to pheomelanogenesls (Flg 6). There are several hnes of 
evidence that support this proposal. 
1) In lethal yellow mice, switching from pheo- to eumelanogen­
esis is induced by the injection of a-MSH [42], probably through an 
increase in tyrosinase activity. Furthermore, Ay I a follicular melano­
cytes possess only 25 -35% of tyrosinase activity of the ala counter-
parts [43].
. . 2) In viable yellow ffilce at the pubertal stage, pheomelanogeneslS 
is enhanced by decreasing tyrosinase activity, whereas eumelano­
genesis is enhanced by increasing tyrosinase activity [10]. Fur­
thermore, tyrosinase activity in the particulate fraction was only 
one-tenth that in hair follicles taken from adult, pheomelanin-pro­
ducing mice as compared with those from pubertal, eumelanin-pro­
ducing mice [44]. 
3) Tyrosinase activity in hair bulbs of wild-type AI A agouti mice 
at the time of pheomelanogenesis is about half of that in ala black 
mice [23,43,45]. 
4) Dibutyryl cyclic adenosine monophosphate stimulates eume­
lanogenesis in cultured hair follicles taken from recessive yellow 
(ele) mice [46]_ The basal level of tyrosinase activity in ele mouse 
skin is about half of that in the black, BIB counterpart [47]. 
5) We have recently shown that human epidermis contains both 
eumelanin and pheomelanin and that psoralen + ultraviolet A 
(PUV A) therapy stimulates eumelanogenesis to a greater extent 
than pheomelanogenesis [24]. This stimulation of eumelanogenesis 
could be related to the increase in the amounts of tyrosinase found in 
the skin after PUVA [48]. 
6) The content of pheomelanin was increased fourfold by cultur­
ing melanocytes established from the skin of C57 black newborn 
mice in the presence of dopa [25]. The enhancement of pheomelano-
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genesis is associated with a decrease in the tyrosinase activity per 
melanosome_ 
7) Imokawa has srudied the recovery process of melanization after 
treatment of B16 melanoma cells with glucosamine to inhibit the 
glucosylation-dependent melanization [29]. The addition of 0.1 % 
(approximately 3 mM) GSH inhibited the recovery process with a 
partial switching t�heomelanOgeneSiS as indicated by a fourfold 
increase in the AHP PTCA ratio. The effect of GSH was shown to 
block the transfer 0 tyrosinase from the Golgi-associated endoplas­
mic reticulum of lysosome (GERL)-coated vesicle system to pre­
melanosomes_ 
8) Some patients with oculocutaneous albinism produce white to 
light yellow hair at birth and, as they grow, their hair tums yellow 
to dark yellow to blond. This phenomenon seems to be associated 
with the tyrosinase activity [49]. Recently, it has also been shown 
that an oculocutaneous albinism patient producing temperarure­
sensitive tyrosinase had white to yellow hair in warmer areas and 
darker hair in cooler areas [30]. 
If it is true that the production of eumelanin is associated with 
higher activities of tyrosinase, then those tissues engaged in eume­
lanogenesis should produce greater concentrations of melanin (i.e., 
eumelanin) than those engaged in pheomelanogenesis. Evidence 
supporting this view is provided in this review. In lambs' hair, the 
switching from eu- to pheomelanogenesis is accompanied by the 
overall reduction in melanin content. A similar phenomenon is 
observed also in human hair. In addition, our HPLC analysis 
showed that the black hair from a/a mice contains approximately 
5% of pure eumelanin, whereas the yellow hair from AY la mice 
contains approximately 1.50/0 of pure pheomelanin [17]. 
Regulation of Eu- and Pheomelanogenesis by 
Tyrosinase Activity 
Low Tyrosinase Activity: When tyrosinase activity in melanosomes 
is low, steady-state concentrations of dopaquinone are kept low, 
allowing excess GSH to add quantitatively to dopaquinone (Fig 6). 
The glu-dopas thus formed are then quantitatively hydrolyzed by 
),-GTP and a peptidase to cys-dopas. Oxidation of cys-dopas, cata­
lyzed by a trace level of dopaquinone, leads to the production of 
pure pheomelanin. The low steady-state level of dopaquinone re­
sults in the following consequences. . 
1) The low dopaquinone concentration keeps the GSH level in 
melanosomes constantly high. This might lead to the suppression of 
tyrosinase transfer to melanosomes from the GERL-coated vesicle 
system [29]. In accordance with this, a reduced uptake of tyrosinase 
by the melanosome has been proposed as one cause of the reduced 
tyrosinase expression in viable yellow mice during pheomelano­
genesis [44]. In addition, if the GSH levels in melanosomes are kept 
at high concentrations, tyrosinase activity might be suppressed; it 
has been shown that Harding-Passay melanoma tyrosinase is inhib­
ited by GSH at concentrations higher than 3 mM [50]. 
2) The quantitative conversion of dopaquinone to glu-dopas pro­
tects GR from inactivation, because GR, a sulfhydryl enzyme [51], 
may be inactivated by dopaquinone through covalent binding, as is 
seen in the suicide inactivation of tyrosinase [52]. It should be added 
that o-quinones such as dopaquinone can bind covalently to proteins 
through the cysteine residues [53]. 
3) A similar type of regulation of enzyme activities exists in )'­
GTP. Mojamdar et at [41] found both tyrosinase and ),-GTP activi­
ties in premelanosomes isolated from B16 melanoma cells but only 
tyrosinase activity in melanized melanosomes. Hu and Buxman [40] 
also found y-GTP in actively melanin-synthesizing retinal pigment 
cells of the Rhesus eye but not in terminally differentiated melano­
cytes. Subsequently, it was shown that y-GTP activities are higher 
in melanoma cells where tyrosinase activities are lower [54]. Thus, 
the addition of L-glutarnine to culrured B 16 melanoma cells caused 
a fivefold increase in tyrosinase activity with a concomitant three­
fold decrease in y-GTP activity [54]. 
High Tyrosinase Activity: When tyrosinase activity in melanosomes 
is higher, the steady-state concentration of dopaquinone is in-
1708 ITO 
Table n. Tissue Concentration of Free Tyrosine in Mice" 
Tissue Tyrosine (pmolfg tissue)' 
Melanoma 
Liver 
Kidney 
Lung 
Heart 
0.36±0.08 
1.01 ±0.15 
1.16 ± 0.15 
0.21 ± 0.03 
0.13 ± 0.03 
• Seven-week-oJd C57 black mice bearing 816 melanoma (0.25-0.42 g) were 
used. 
I Analyzed by HPLC with electrochemical detection (at 900 mV versus an Agf 
AgO electrode). 
creased, resulting in a rapid decrease in the GSH level. This may lead 
to the following consequences. 
1) The lower level of GSH facilitates the transfer of tyrosinase 
into melanosomes [29]. In addition, the lower level of GSH may 
possibly enhance tyrosinase activity [50]. 
2) The excess dopaquinone may cause the inactivation of GR, 
resulting in a decrease in the GSH/GSSG ratio [39,40]. The GR 
activity may also be regulated by the level of glu-dopas. Bilzer et al 
[55] showed that S-conjugates of GSH can influence the GSH/ 
GSSG status of hepatocytes by inhibiting GR activity. It is thus 
possible that glu-dopas, S-conjugates of GSH, act as reversible inhib­
itors of GR activity. 
3) )I-GTP activities are lower in melanoma cells where tyrosinase 
activities are higher [54]. The )I-GTP activity may also be regulated 
by intermediates in melanosomes. Thus, dopa and glu-dopas at 
1 mM concentration inhibit in vitro )I-GTP activity to 10-20% of 
the control value [54]. 
Glu-dopas may accumulate rapidly in the initial course of eume­
lanogenesis. To some extent glu-dopas thus formed are converted to 
pheomelanin via cys-dopas. However, as the )I-GTP activity may 
not be sufficiently high, most of glu-dopas are rapidly oxidized by 
dopaquinone to soluble, indolic melanin (melanoid). In model ex­
periments melanins formed from dopa and GSH in ratios 2: 1 to 1 : 1 
were found to be soluble even at 10 mM concentration [12]. It is 
therefore likely that these melanoid black polymers are released 
from the melanosome into the cytoplasm. Even if some of the glu­
dopas or cys-dopas are incorporated into eumelanin that is being 
formed, they do not constitute significant portions of the melanin as 
long as GSH levels are kept minimal. Thus, eumelanin in melano­
somes isolated from B16 melanoma constitutes approximately 
1.5 M (30%) concentration when calculated on the basis of molecu­
lar weight of the monomer units [18]. This concentration is three 
orders of magnitude higher than the expected GSH level (approxi­
mately 1 mM) in the melanosome [50]. Although the intracellular 
concentration of the precursor amino acid tyrosine is also at a milli­
molar range (Table II), it can be taken u!' rar.idly and effectively into 
melanocytes by two transport systems l56 . 
The above discussion should also apply to the agouti pattern 
formation, i.e., the alternating synthesis of eu-, pheo-, and again 
eumelanin in the same follicular melanocyte. The initial stage of 
melanogenesis in agouti melanocytes may be governed by the rela­
tively high tyrosinase activity, leading to eumelanogenesis (see Fig 
6, high tyrosinase activity). At the time of the black-to-yellow 
switch, tyrosinase activity declines, resulting in a lowered concen­
tration of dopaquinone and the subsequent series of events depicted 
in Fig 6 (low tyrosinase activity). The decreased level of tyrosinase 
activity in the second stage leads to pheomelanogenesis. Gene prod­
ucts, encoded by the agouti locus, may act through the follicular 
environment to modulate one or more membrane signal-transduc­
tion mechanisms to lower tyrosinase activity [57]. 
Finally, it should be noted that mixed-type melanogenesis may 
take place when tyrosinase activity in mefanosomes is not high 
enough to give rise to pure eumelanogenesis [2,3]. In fact, our 
HPLC analyses of hair, feathers, and melanomas from various 
sources have shown that most of the melanins are co-polymers of 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
eu- and pheomelanin. Dopachrome tautomerase, originally called 
dopachrome conversion factor, catalyzes the conversion of do­
pachrome to 5,6-dihydroxyindole-2-carboxylic acid and accelerates 
the rate of eumelanogenesis [4]. Although it has been groposed that 
this enzyme is involved in the switching mechanism l58], its role in 
the regulation of pheomelanogenesis has not been determined. 
I am grateful to Dr. AJ. Tholl] (University ofNewClJStie Upon Tyne) and Dr. N.H . 
Granholm (South Dakota State University) for their critical reading of the manll­
script. 
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